FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

23593111000001101: Vizarsin 100mg tablets (Krka UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-Dec 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2576521000001110 Vizarsin 100mg tablets (Krka UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2576541000001117 Vizarsin 100mg tablets (Krka UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vizarsin 100mg tablets (Krka UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Vizarsin 100mg tablets (Krka UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Vizarsin 100mg tablets (Krka UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Vizarsin 100mg tablets (Krka UK Ltd) Is a Product containing precisely sildenafil (as sildenafil citrate) 100 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Vizarsin 100mg tablets (Krka UK Ltd) Has active ingredient Sildenafil citrate false Inferred relationship Existential restriction modifier
Vizarsin 100mg tablets (Krka UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Vizarsin 100mg tablets (Krka UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Vizarsin 100mg tablets (Krka UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Vizarsin 100mg tablets (Krka UK Ltd) Has specific active ingredient Sildenafil citrate true Inferred relationship Existential restriction modifier
Vizarsin 100mg tablets (Krka UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Vizarsin 100mg tablets (Krka UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Sildenafil true Inferred relationship Existential restriction modifier
Vizarsin 100mg tablets (Krka UK Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Vizarsin 100mg tablets (Krka UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Vizarsin 100mg tablets (Krka UK Ltd) Is a Vizarsin true Inferred relationship Existential restriction modifier
Vizarsin 100mg tablets (Krka UK Ltd) Has basis of strength substance Sildenafil true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Vizarsin 100mg tablets (Krka UK Ltd) 4 tablet Has AMP True Vizarsin 100mg tablets (Krka UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start